Zomedica Corp. SEC filings ZOMDF

Zomedica Corp. has 482 filings in SEC EDGAR's recent list, going back to Sep 8, 2016. Its latest annual report, Form 10-K, was filed on Mar 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.

Zomedica Corp. SEC filings
Form Description Filed Period
8-K Current report
Results of operations
Nov 4, 2026 Nov 4, 2026
10-Q Quarterly report Nov 4, 2026 Sep 30, 2026
4 Insider transaction Aug 7, 2026 Aug 5, 2026
4 Insider transaction Aug 7, 2026 Aug 5, 2026
4 Insider transaction Aug 7, 2026 Aug 5, 2026
8-K Current report
Results of operations
Aug 5, 2026 Aug 5, 2026
10-Q Quarterly report Aug 5, 2026 Jun 30, 2026
8-K Current report
Shareholder vote results
Jun 11, 2026 Jun 10, 2026
4 Insider transaction May 26, 2026 May 21, 2026
4 Insider transaction May 21, 2026 May 18, 2026
4 Insider transaction May 21, 2026 May 10, 2026
4 Insider transaction May 14, 2026 May 12, 2026
4 Insider transaction May 11, 2026 May 8, 2026
4 Insider transaction May 8, 2026 May 8, 2026
8-K Current report
Results of operations
May 6, 2026 May 6, 2026
10-Q Quarterly report May 6, 2026 Mar 31, 2026
DEF 14A Proxy statement Apr 27, 2026 Apr 24, 2026
DEFA14A Additional proxy material Apr 24, 2026 —
PRE 14A Preliminary proxy statement Apr 14, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 16, 2026 Mar 16, 2026
10-K Annual report Mar 16, 2026 Dec 31, 2025
4 Insider transaction Nov 18, 2025 Mar 17, 2025
4 Insider transaction Nov 18, 2025 Nov 17, 2025
4 Insider transaction Nov 18, 2025 Nov 17, 2025
4 Insider transaction Nov 18, 2025 Nov 17, 2025
4 Insider transaction Nov 18, 2025 Nov 17, 2025
4 Insider transaction Nov 18, 2025 Nov 17, 2025
4 Insider transaction Nov 18, 2025 Nov 17, 2025
4 Insider transaction Nov 14, 2025 Nov 13, 2025
4 Insider transaction Nov 12, 2025 Nov 10, 2025
4 Insider transaction Nov 10, 2025 Nov 7, 2025
4 Insider transaction Nov 7, 2025 Nov 6, 2025
8-K Current report
Results of operations
Nov 4, 2025 Nov 4, 2025
10-Q Quarterly report Nov 4, 2025 Sep 30, 2025
8-A12G Form 8-a12g Aug 20, 2025 —
4 Insider transaction Aug 13, 2025 Aug 11, 2025
4 Insider transaction Aug 12, 2025 Aug 11, 2025
4 Insider transaction Aug 12, 2025 Aug 8, 2025
8-K Current report
Results of operations
Aug 6, 2025 Aug 6, 2025
10-Q Quarterly report Aug 6, 2025 Jun 30, 2025
4 Insider transaction Jun 16, 2025 Jun 12, 2025
4 Insider transaction Jun 16, 2025 Jun 12, 2025
4 Insider transaction Jun 16, 2025 Jun 12, 2025
4 Insider transaction Jun 16, 2025 Jun 12, 2025
8-K Current report
Shareholder vote results
Jun 11, 2025 Jun 10, 2025
DEFA14A Additional proxy material Jun 6, 2025 —
DEFA14A Additional proxy material May 30, 2025 —
DEFA14A Additional proxy material May 30, 2025 —
4 Insider transaction May 21, 2025 May 21, 2025
4 Insider transaction May 20, 2025 May 19, 2025
4 Insider transaction May 20, 2025 May 19, 2025
8-K Current report
Results of operations
May 15, 2025 May 15, 2025
10-Q Quarterly report May 15, 2025 Mar 31, 2025
DEFA14A Additional proxy material May 13, 2025 —
DEFA14A Additional proxy material Apr 30, 2025 —
ARS Annual report to shareholders Apr 30, 2025 Dec 31, 2024
DEF 14A Proxy statement Apr 30, 2025 Apr 30, 2025
8-K Current report
Officer or director change
Apr 30, 2025 Apr 25, 2025
4/A Primary document Mar 27, 2025 Mar 17, 2025
4 Insider transaction Mar 20, 2025 Mar 17, 2025
4 Insider transaction Mar 19, 2025 Mar 17, 2025
4 Insider transaction Mar 18, 2025 Mar 17, 2025
4 Insider transaction Mar 18, 2025 Mar 17, 2025
4 Insider transaction Mar 18, 2025 Mar 17, 2025
4 Insider transaction Mar 18, 2025 Mar 17, 2025
4 Insider transaction Mar 18, 2025 Mar 17, 2025
4 Insider transaction Mar 18, 2025 Mar 17, 2025
4 Insider transaction Mar 18, 2025 Mar 17, 2025
8-K Current report
Results of operations
Mar 14, 2025 Mar 13, 2025
10-K Annual report Mar 13, 2025 Dec 31, 2024
25-NSE Delisting notice Mar 13, 2025 —
8-K Current report
Listing notice
Mar 5, 2025 Mar 4, 2025
4 Insider transaction Feb 24, 2025 Feb 21, 2025
4 Insider transaction Jan 3, 2025 Jan 1, 2025
3 Initial insider ownership Jan 3, 2025 Jan 1, 2025
8-K Current report
Officer or director change
Dec 19, 2024 Dec 19, 2024
4/A Form 4 Nov 26, 2024 Nov 11, 2024
8-K Current report
Material agreement
Nov 19, 2024 Nov 15, 2024
4 Insider transaction Nov 13, 2024 Nov 11, 2024
4 Insider transaction Nov 13, 2024 Nov 11, 2024
4 Insider transaction Nov 13, 2024 Nov 11, 2024
4 Insider transaction Nov 13, 2024 Nov 11, 2024
4 Insider transaction Nov 13, 2024 Nov 11, 2024
4 Insider transaction Nov 13, 2024 Nov 11, 2024
4 Insider transaction Nov 13, 2024 Nov 11, 2024
4 Insider transaction Nov 13, 2024 Nov 11, 2024
4 Insider transaction Nov 13, 2024 Nov 11, 2024
4 Insider transaction Nov 13, 2024 Nov 12, 2024
4 Insider transaction Nov 12, 2024 Nov 11, 2024
4 Insider transaction Nov 12, 2024 Nov 11, 2024
4 Insider transaction Nov 12, 2024 Nov 11, 2024
8-K Current report
Results of operations
Nov 8, 2024 Nov 7, 2024
10-Q Quarterly report Nov 7, 2024 Sep 30, 2024
UPLOAD Letter from the SEC Oct 16, 2024 —
CORRESP Letter to the SEC Oct 9, 2024 —
UPLOAD Letter from the SEC Sep 16, 2024 —
4 Insider transaction Sep 5, 2024 Sep 5, 2024
4 Insider transaction Aug 28, 2024 Aug 28, 2024
4 Insider transaction Aug 20, 2024 Aug 20, 2024
8-K Current report
Results of operations
Aug 14, 2024 Aug 14, 2024
8-K Current report
Officer or director change
Aug 14, 2024 Aug 14, 2024
10-Q Quarterly report Aug 14, 2024 Jun 30, 2024
S-8 Employee stock plan registration Jul 3, 2024 —
4 Insider transaction Jun 13, 2024 Jun 12, 2024
4 Insider transaction Jun 12, 2024 Jun 10, 2024
4 Insider transaction Jun 11, 2024 Jun 10, 2024
8-K Current report
Shareholder vote results
Jun 7, 2024 Jun 6, 2024
4 Insider transaction May 17, 2024 May 17, 2024
4 Insider transaction May 17, 2024 May 16, 2024
4 Insider transaction May 15, 2024 May 13, 2024
4 Insider transaction May 15, 2024 May 14, 2024
4 Insider transaction May 14, 2024 May 13, 2024
4 Insider transaction May 14, 2024 May 13, 2024
4 Insider transaction May 13, 2024 May 13, 2024
8-K Current report
Results of operations
May 9, 2024 May 9, 2024
10-Q Quarterly report May 9, 2024 Mar 31, 2024
ARS Annual report to shareholders Apr 29, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 26, 2024 —
DEF 14A Proxy statement Apr 26, 2024 Dec 31, 2023
8-K Current report
Results of operations
Apr 4, 2024 Apr 1, 2024
10-K Annual report Apr 1, 2024 Dec 31, 2023
8-K Current report
Listing notice
Mar 15, 2024 Mar 13, 2024
8-K Current report
Shareholder vote results
Feb 29, 2024 Feb 28, 2024
DEFA14A Additional proxy material Feb 20, 2024 —
DEFA14A Additional proxy material Feb 6, 2024 —
DEFA14A Additional proxy material Jan 31, 2024 —
DEFA14A Additional proxy material Jan 26, 2024 —
DEFA14A Additional proxy material Jan 24, 2024 —
DEFA14A Additional proxy material Jan 17, 2024 —
DEF 14A Proxy statement Jan 17, 2024 Jan 16, 2024
PRE 14A Preliminary proxy statement Jan 5, 2024 Jan 5, 2024
4/A Primary document Dec 18, 2023 Dec 15, 2023
4 Insider transaction Dec 18, 2023 Dec 15, 2023
4 Insider transaction Nov 20, 2023 Nov 17, 2023
4 Insider transaction Nov 17, 2023 Nov 17, 2023
4 Insider transaction Nov 16, 2023 Nov 15, 2023
4 Insider transaction Nov 14, 2023 Nov 7, 2023
8-K Current report
Results of operations
Nov 13, 2023 Nov 13, 2023
10-Q Quarterly report Nov 13, 2023 Sep 30, 2023
4 Insider transaction Nov 9, 2023 Nov 7, 2023
3 Initial insider ownership Nov 9, 2023 Nov 6, 2023
8-K Current report
Material agreement, Agreement ended
Oct 10, 2023 Oct 4, 2023
8-K Current report
Listing notice
Sep 14, 2023 Sep 12, 2023
8-K Current report
Material agreement, Acquisition or sale of assets
Sep 6, 2023 Sep 4, 2023
8-K Current report
Results of operations
Aug 10, 2023 Aug 10, 2023
10-Q Quarterly report Aug 10, 2023 Jun 30, 2023
8-K Current report
Shareholder vote results
Jun 14, 2023 Jun 13, 2023
4 Insider transaction May 26, 2023 May 26, 2023
4 Insider transaction May 25, 2023 May 25, 2023
8-K Current report
Results of operations
May 11, 2023 May 11, 2023
10-Q Quarterly report May 11, 2023 Mar 31, 2023
8-K Current report
Material agreement
May 11, 2023 May 10, 2023
8-K Current report
Other events
May 9, 2023 May 8, 2023
ARS Annual report to shareholders Apr 28, 2023 Dec 31, 2022
DEFA14A Additional proxy material Apr 28, 2023 —
DEF 14A Proxy statement Apr 28, 2023 Jun 13, 2023
4 Insider transaction Mar 20, 2023 Mar 16, 2023
3 Initial insider ownership Mar 20, 2023 Mar 16, 2023
8-K Current report
Officer or director change
Mar 17, 2023 Mar 15, 2023
8-K Current report
Results of operations
Mar 15, 2023 Mar 15, 2023
10-K Annual report Mar 15, 2023 Dec 31, 2022
8-K Current report
Results of operations
Feb 9, 2023 Feb 8, 2023
8-K Current report
Material agreement, Agreement ended, Other events
Jan 24, 2023 Jan 17, 2023
8-K Current report
Material agreement, Other events
Jan 20, 2023 Jan 13, 2023
4 Insider transaction Dec 13, 2022 Dec 9, 2022
4 Insider transaction Dec 13, 2022 Dec 9, 2022
4 Insider transaction Dec 13, 2022 Dec 9, 2022
4 Insider transaction Dec 13, 2022 Dec 9, 2022
4 Insider transaction Dec 13, 2022 Dec 9, 2022
4 Insider transaction Dec 13, 2022 Dec 9, 2022
4 Insider transaction Dec 13, 2022 Dec 9, 2022
8-K Current report
Results of operations
Nov 14, 2022 Nov 14, 2022
10-Q Quarterly report Nov 14, 2022 Sep 30, 2022
4 Insider transaction Oct 6, 2022 Oct 4, 2022
4 Insider transaction Sep 2, 2022 Aug 31, 2022
3 Initial insider ownership Sep 2, 2022 Aug 23, 2022
8-K Current report
Officer or director change
Aug 24, 2022 Aug 23, 2022
8-K Current report
Results of operations
Aug 15, 2022 Aug 15, 2022
10-Q Quarterly report Aug 15, 2022 Jun 30, 2022
8-K Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Other events
Jul 20, 2022 Jul 15, 2022
8-K Current report
Other events
Jul 11, 2022 Jul 7, 2022
8-K Current report
Acquisition or sale of assets, Unregistered share sale, Other events
Jul 11, 2022 Jul 1, 2022
3 Initial insider ownership Jun 22, 2022 Jun 13, 2022
3 Initial insider ownership Jun 21, 2022 Jun 13, 2022
8-K Current report
Material agreement, Other events
Jun 21, 2022 Jun 14, 2022
8-K Current report
Officer or director change
Jun 15, 2022 Jun 13, 2022
8-K Current report
Shareholder vote results
Jun 9, 2022 Jun 7, 2022
8-K Current report
Results of operations
May 10, 2022 May 10, 2022
10-Q Quarterly report May 10, 2022 Mar 31, 2022
DEFA14A Additional proxy material Apr 26, 2022 —
DEF 14A Proxy statement Apr 26, 2022 Jun 7, 2022
4 Insider transaction Mar 1, 2022 Feb 25, 2022
8-K Current report
Results of operations
Mar 1, 2022 Mar 1, 2022
10-K Annual report Mar 1, 2022 Dec 31, 2021
8-K/A Amended current report Dec 10, 2021 Oct 1, 2021
8-K Current report
Officer or director change
Nov 26, 2021 Nov 19, 2021
4 Insider transaction Nov 22, 2021 Nov 18, 2021
8-K Current report
Other events
Nov 18, 2021 Nov 16, 2021
8-K Current report
Results of operations
Nov 12, 2021 Nov 12, 2021
10-Q Quarterly report Nov 12, 2021 Sep 30, 2021

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
ZOMDF (OTC)
Fiscal year ends
December 31
Incorporated in
Alberta, Canada
Headquarters
Ann Arbor, MI
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1684144
Former names
Zomedica Pharmaceuticals Corp. (until Sep 28, 2020)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.